Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Rich Upton - aVenture Research

Rich Upton

AddedMar 31, 2024

UpdatedOct 18, 2026

Rich Upton

Rich Upton

Co-Founder, Harbor Light Capital Partners

Rich Upton's Career

Harbor Light Capital Partners

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Investment FirmKeene, NH, US

Co-Founder

Castlewood Surgical

Series C$1.4MDallas, TX, US

Board Member· Board

Anuncia

Seed$1kScottsdale, AZ, US

Board Member· Board

Alcyone Lifesciences

Series B$38.6MLowell, MA, US

Board Member· Board

Courtagen Life Sciences

$65MWoburn, MA, US

Board Member· Board

People Similar to Rich Upton

Magda MarquetBoard Member · Arcturus Therapeutics Holdings

Daniel LevangieFounder · Aton Partners

Vijay AgarwalFounder & CEO · Alpheus Medical

Imran EbaBoard Member · Alpheus Medical

Nicole VitulloBoard Member · BioScience Managers

Leadership at Harbor Light Capital Partners

Jeff MillerBoard Member

Todd WardenCo-Founder

Similar to Harbor Light Capital Partners

Harbor Pacific CapitalPalo Alto, CA, USest. 2009Harbor Pacific CapitalPalo Alto, CA, US · est. 2009

Harbor Pacific Capital: A California-based venture capital firm offering growth equity investments since 2009.

Investment Firm7

Hatteras Venture PartnersDurham, NC, USest. 2000Hatteras Venture PartnersDurham, NC, US · est. 2000

Hatteras Venture Partners: A US-based venture capital firm investing in healthcare and biopharmaceutical sectors.

Investment Firm30

Lightchain CapitalSt. Louis, MO, USest. 2018Lightchain CapitalSt. Louis, MO, US · est. 2018

Venture capital fund investing in early-stage life sciences firms for improved cancer outcomes.

Investment Firm3

Harmony PartnersNew York City, NY, USest. 2010Harmony PartnersNew York City, NY, US · est. 2010

Harmony Partners: A unique venture capital firm investing in high-growth tech companies globally since 2010.

Investment Firm8

Similar to Castlewood Surgical

Arbor Surgical TechnologiesIrvine, CA, USMedical Devicesest. 2002Arbor Surgical TechnologiesIrvine, CA, US · est. 2002

Arbor Surgical Technologies: Innovating in heart valve replacement with advanced medical devices and tools.

Series C · $50.8M30

CircumFix SolutionsPiperton, TN, USMedical Devicesest. 2020CircumFix SolutionsPiperton, TN, US · est. 2020

CircumFix Solutions: A Tennessee-based medical device startup innovating in cardiovascular surgery since 2020.

Buck SurgicalSt. Louis, MO, USSurgical Devicesest. 2021Buck SurgicalSt. Louis, MO, US · est. 2021

Revolutionizing surgical care with innovative devices for life and limb-preserving treatments.

Seed · $676.5k2

Silk Road MedicalSunnyvale, CA, USSurgical Devicesest. 2007Silk Road MedicalSunnyvale, CA, US · est. 2007

Silk Road Medical develops and manufactures minimally invasive surgical devices for transcarotid artery revascularization and stroke prevention.

Leadership at Anuncia

David DonabedianBoard Member

PJ AnandBoard Member

Elsa Chi AbruzzoBoard Member

Similar to Anuncia

CereVascAuburndale, FL, USMedical Devicesest. 2014CereVascAuburndale, FL, US · est. 2014

CereVasc, a medical device company, innovates minimally invasive treatments for neurological diseases.

Series A · $44M14

BeckerSmith MedicalIrvine, CA, USMedical Devicesest. 2009BeckerSmith MedicalIrvine, CA, US · est. 2009

BeckerSmith Medical: Innovating CSF management with FLOWSAFE, a fully-automated, programmable system.

BrainSpaceBothell, WA, USMedical Devicesest. 2021BrainSpaceBothell, WA, US · est. 2021

BrainSpace: Collaborating to eliminate long-term handicaps from brain injuries.

CsfrefreshRedmond, WA, USMedical DevicesCsfrefreshRedmond, WA, US

Innovative biomedical device developer creating a treatment for Alzheimer’s disease by enhancing brain toxin removal.

Leadership at Alcyone Lifesciences

Steve OesterleBoard Member

Edgar JannottaBoard Member

Similar to Alcyone Lifesciences

PolyCore TherapeuticsPará, BRCNS Treatmentsest. 2015PolyCore TherapeuticsPará, BR · est. 2015

PolyCore Therapeutics: Innovating breakthrough CNS disease treatments through dedicated life science research.

Seed · $6.5M11

MapLight TherapeuticsPalo Alto, CA, USDrug Discovery, Therapeuticsest. 2018MapLight TherapeuticsPalo Alto, CA, US · est. 2018

Maplight: A biopharmaceutical firm innovating CNS disorder therapeutics via drug discovery platform.

Public · $518.8M67

CuraSen TherapeuticsSan Carlos, CA, USDrugsest. 2016CuraSen TherapeuticsSan Carlos, CA, US · est. 2016

CuraSen: A biotech firm innovating drugs for CNS and neurodegenerative diseases enhancement.

Series B · $95.9M38

AGY TherapeuticsSan Francisco, CA, USCNS Treatmentsest. 1998AGY TherapeuticsSan Francisco, CA, US · est. 1998

AGY Therapeutics: Innovating CNS treatments through unique gene discovery and pathway mapping.

Series C · $22M75

Leadership at Courtagen Life Sciences

Brendan McKernanFounder

Thomas L Fairfield "Tom"Board Member

Joe KeeganBoard Member

Similar to Courtagen Life Sciences

CasTag BiosciencesDurham, NC, USBiotechnology, Cell Therapiesest. 2020CasTag BiosciencesDurham, NC, US · est. 2020

CasTag Biosciences: Innovating regenerative medicine and cell biology for faster scientific discovery.

Angel · $280.7k2

QuintarabioSouth San Francisco, CA, USGenetic Sequencing, Life Science Researchest. 2005QuintarabioSouth San Francisco, CA, US · est. 2005

Quintara Biosciences: A biotech firm offering genetic sequencing and life science research services.

Gentel BiosciencesMadison, WI, USProfiling, Proteomicsest. 2000Gentel BiosciencesMadison, WI, US · est. 2000

Gentel Biosciences: A leading provider of proteomics profiling tools and services, based in Madison, Wisconsin.

Glyphic BiotechnologiesNew York City, NY, USProtein Sequencingest. 2021Glyphic BiotechnologiesNew York City, NY, US · est. 2021

Glyphic: A global consulting firm providing innovative business solutions with Fortune 1000 companies using top tech platforms.

Angel · $10.6M25